Winfield Associates’s Accendra Health ACH Stock Holding History

Winfield Associates’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-162	Closed	-$5K	–	864
2017 Q2	$5K	Buy	+162	New	+$5.32K	﹤0.01%	528

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Winfield Associates's ACH Position: Q3 2017 in Review

Winfield Associates sold out of Accendra Health (ACH) in Q3 2017, closing a stake of 162 shares — an estimated $5K sold.

Winfield Associates first reported a position in ACH in Q2 2017 and held it in 1 quarter. The position peaked at $5K in Q2 2017. 260 funds tracked by Wall St. Rank hold ACH as of Q3 2017.

Winfield Associates reported no remaining Accendra Health position as of Q3 2017 after selling out during the quarter.
Winfield Associates sold 162 Accendra Health shares in Q3 2017, an estimated $5K.
Winfield Associates first reported a position in Accendra Health in Q2 2017 and held it in 1 quarter.
Winfield Associates's Accendra Health position peaked at $5K in Q2 2017.
260 funds tracked by Wall St. Rank held Accendra Health as of Q3 2017.

Based on Winfield Associates's 13F filing for Q3 2017, filed 6 Nov 2017.